Log in or create an account for full access to this data.
Create a free account or log in to use this tool.
Create a free account or log in to explore DrugBank data.
DB11475ExperimentalVet approvedSmall molecule
Tylosin is a bacteriostatic macrolide antibiotic and feed additive used in veterinary medicine. It has a broad spectrum of activity against Gram-positive organisms and a limited range of Gram-negative organisms.... Tylosin is produced as a fermentation product of Streptomyces fradiae.
- Mechanism
- Curator reviewed
Pharmacologically active on 23S ribosomal RNA
- Formula / weight
- C46H77NO17 · 916.1001 g/mol (avg)
- Also known as
- Tylocine · Tylosin A
Resolves to
Clinical / RWD
Structure
InChIKey
WBPYTXDJUQJLPQ-VMXQISHHSA-NSMILESCC[C@H]1OC(=O)C[C@@H](O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)[C@@H](O[C@H]3C[C@@](C)(O)[C@@H](O)[C@H](C)O3)[C@@H]([C@H]2O)N(C)C)[C@@H](CC=O)C[C@@H](C)C(=O)\C=C\C(\C)=C\[C@@H]1CO[C@@H]1O[C@H](C)[C@@H](O)[C@@H](OC)[C@H]1OCWhat you can answer from here — as of August 30, 2026
Which companies are running trials of Tylosin, in which indications and phases, and which of those programs are still active?